Dikkat Eksikliği ve Hiperaktivite Bozukluğunda Yaşam Kalitesine Bakış
Özet
Referanslar
Altin, M. A. L., Durell, T. M., Adler, L. A., Williams, D. V., Deldar, A., Mcgough, J. J., Glaser, P. E., Rubin, R. L., Sarkis, E. S., Pigott, T. A., & Boardman, B. K. (2014). In Psychopharmacology TAf (Ed.), 4th International Congress on Psychopharmacology, Turkey, 2014.
Becker, A., Roessner, V., Breuer, D., Döpfner, M., & Rothenberger, A. (2011). Relationship between quality of life and psychopathological profile: Data from an observational study in children with ADHD. European Child & Adolescent Psychiatry, 20(2), 267–276. https://doi.org/10.1007/s00787-010-0143-7
Biederman, J., Faraone, S. V., Spencer, T. J., Mick, E., Monuteaux, M. C., & Aleardi, M. (2006). Functional impairments in adults with self-reports of diagnosed ADHD. The Journal of Clinical Psychiatry, 67(4), 524–540. https://doi.org/10.4088/jcp.v67n0408
Biederman, J., Spencer, T. J., Newcorn, J. H., Gao, H., Milton, D. R., Feldman, P. D., & Witte, M. M. (2007). Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: A meta-analysis of controlled clinical trial data. Psychopharmacology (Berl), 190(1), 31-41. https://doi.org/10.1007/s00213-006-0600-6
Brown, R. T., Perwien, A., Faries, D. E., Kratochvil, C. J., & Vaughan, B. S. (2006). Atomoxetine in the management of children with ADHD: Effects on quality of life and school functioning. Clinical Pediatrics (Phila), 45(9), 819-827. https://doi.org/10.1177/000992280604500902
Cheng, J. Y., Chen, R. Y., Ko, J. S., & Ng, E. M. (2007). Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis. Psychopharmacology (Berl), 194(2), 197-209. https://doi.org/10.1007/s00213-007-0782-9
Flapper, B. C., Schoemaker, M. M., Flapper Boudien, C. T., & Schoemaker Marina, M. (2008). Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD. Developmental Medicine & Child Neurology, 50(4), 294-299. https://doi.org/10.1111/j.1469-8749.2008.03080.x
Flapper, B. C., Schoemaker, M. M., Flapper, Boudien C. T., & Schoemaker, Marina M. (2008). Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD. Developmental Medicine & Child Neurology, 50(4), 294–299. https://doi.org/10.1111/j.1469-8749.2008.03087.x
Kandemir, H., Kılıç, B. G., Ekinci, S., & Yüce, M. (2014). An evaluation of the quality of life of children with ADHD and their families. Anadolu Psikiyatri Dergisi, 15(3), 265–271. https://doi.org/10.5455/apd.35727
Klassen, A. F., Miller, A., & Fine, S. (2004). Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Pediatrics, 114(5), e541-e547. https://doi.org/10.1542/peds.2004-0613
Matza, L. S., Rentz, A. M., Secnik, K., Swensen, A. R., Revicki, D. A., Michelson, D., et al. (2004). The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder. Journal of Developmental & Behavioral Pediatrics, 25(3), 166–174. https://doi.org/10.1097/00004703-200406000-00002
Newcorn, J. H., Spencer, T. J., Biederman, J., Milton, D. R., & Michelson, D. (2005). Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 44(3), 240-248. https://doi.org/10.1097/01.chi.0000155412.69909.32
Özkan, S. (1999). Yaşam Kalitesinin Ölçülmesi, WHOQOL-100 ve WHOQOL-BREF. Psikiyatri, Psikoloji, Psikofarmakoloji Dergisi, 7(2), 5-13.
Perwien, A. R., Faries, D. E., Kratochvil, C. J., Sumner, C. R., Kelsey, D. K., & Allen, A. J. (2004). Improvement in health-related quality of life in children with ADHD: An analysis of placebo controlled studies of atomoxetine. Journal of Developmental and Behavioral Pediatrics, 25(4), 264-271. https://doi.org/10.1097/00004703-200408000-00005
Perwien, A. R., Kratochvil, C. J., Faries, D. E., Vaughan, B. S., Spencer, T., & Brown, R. T. (2006). Atomoxetine treatment in children and adolescents with attention-deficit hyperactivity disorder: What are the long-term health-related quality-of-life outcomes? Journal of Child and Adolescent Psychopharmacology, 16(6), 713-724. https://doi.org/10.1089/cap.2006.16.713
Pongwilairat, K., Louthrenoo, O., Charnsil, C., & Witoonchart, C. (2005). Quality of life of children with attention-deficit/hyperactivity disorder. Journal of the Medical Association of Thailand, 88(8), 1062-1066.
Prasad, S., Harpin, V., Poole, L., Zeitlin, H., Jamdar, S., & Puvanendran, K. (2007). A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD). Current Medical Research and Opinion, 23(2), 379-394. https://doi.org/10.1185/030573107X179380
Rebok, G., Riley, A., Forrest, C., Starfield, B., Green, B., Robertson, J., & et al. (2001). Elementary school-aged children's reports of their health: A cognitive interviewing study. Quality of Life Research, 10(1), 59-70. https://doi.org/10.1023/A:1016784312151
Riley, A. W., Coghill, D., Forrest, C. B., Lorenzo, M. J., Ralston, S. J., & Spiel, G. (2006). Validity of the health-related quality of life assessment in the ADORE study: Parent Report Form of the CHIP-Child Edition. European Child & Adolescent Psychiatry, 15(Suppl 1), i63–i71. https://doi.org/10.1007/s00787-006-0511-2
Riley, A. W., Spiel, G., Coghill, D., Dopfner, M., Falissard, B., Lorenzo, M. J., Preuss, U., & Ralston, S. J. (2006). Factors related to health-related quality of life (HRQoL) among children with ADHD in Europe at entry into treatment. European Child & Adolescent Psychiatry, 15(Suppl 1), i38-i45. https://doi.org/10.1007/s00787-006-0529-4
Üneri, Ö., & NÇ, M. (2007). Çocuklarda yaşam kalitesi kavramı ve yaşam kalitesi ölçeklerinin gözden geçirilmesi. Çocuk ve Gençlik Ruh Sağlığı Dergisi, 14(1), 48–56. https://doi.org/10.5455/cjpsy.10816
Üneri, Ö., Turgut, S., Öner, P., Bodur, Ş., & Rezaki, B. (2010). Quality of life in 8–12 years old children with attention deficit hyperactivity disorder. Çocuk ve Gençlik Ruh Sağlığı Dergisi/Turkish Journal of Child and Adolescent Mental Health, 17(1), 27–32. https://doi.org/10.1002/psp.781
Varni, J. W., Seid, M., & Kurtin, P. S. (2001). PedsQL™ 4.0: Reliability and validity of the Pediatric Quality of Life Inventory™ Version 4.0 Generic Core Scales in healthy and patient populations. Medical Care, 39(8), 800-812. https://doi.org/10.1097/01.MLR.0000017652.00300.55
Wallander, J. L., Schmitt, M., & Koot, H. M. (2001). Quality of life measurement in children and adolescents: Issues, instruments, and applications. Journal of Clinical Psychology, 57(4), 571-585. https://doi.org/10.1002/jclp.1041
Wehmeier, P. M., Schacht, A., & Barkley, R. A. (2010). Social and emotional impairment in children and adolescents with ADHD and the impact on quality of life. Journal of Adolescent Health, 46(3), 209–217. https://doi.org/10.1016/j.jadohealth.2009.07.015
Wehmeier, P. M., Schacht, A., Escobar, R., Hervas, A., & Dickson, R. (2012). Health-related quality of life in ADHD: A pooled analysis of gender differences in five atomoxetine trials. ADHD Attention Deficit and Hyperactivity Disorders, 4(1), 25–35. https://doi.org/10.1007/s12402-012-0083-7
Weiss, M. D., Gibbins, C., Goodman, D. W., Hodgkins, P. S., Landgraf, J. M., & Faraone, S. V. (2010). Moderators and mediators of symptoms and quality of life outcomes in an open-label study of adults treated for attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 71(4), 381–388. https://doi.org/10.4088/JCP.08m04510
Yang, P., Hsu, H. Y., Chiou, S. S., & Chao, M. C. (2007). Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: Results from a Taiwanese sample. Australian & New Zealand Journal of Psychiatry, 41(12), 998-1004. https://doi.org/10.1080/00048670701670183
Referanslar
Altin, M. A. L., Durell, T. M., Adler, L. A., Williams, D. V., Deldar, A., Mcgough, J. J., Glaser, P. E., Rubin, R. L., Sarkis, E. S., Pigott, T. A., & Boardman, B. K. (2014). In Psychopharmacology TAf (Ed.), 4th International Congress on Psychopharmacology, Turkey, 2014.
Becker, A., Roessner, V., Breuer, D., Döpfner, M., & Rothenberger, A. (2011). Relationship between quality of life and psychopathological profile: Data from an observational study in children with ADHD. European Child & Adolescent Psychiatry, 20(2), 267–276. https://doi.org/10.1007/s00787-010-0143-7
Biederman, J., Faraone, S. V., Spencer, T. J., Mick, E., Monuteaux, M. C., & Aleardi, M. (2006). Functional impairments in adults with self-reports of diagnosed ADHD. The Journal of Clinical Psychiatry, 67(4), 524–540. https://doi.org/10.4088/jcp.v67n0408
Biederman, J., Spencer, T. J., Newcorn, J. H., Gao, H., Milton, D. R., Feldman, P. D., & Witte, M. M. (2007). Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: A meta-analysis of controlled clinical trial data. Psychopharmacology (Berl), 190(1), 31-41. https://doi.org/10.1007/s00213-006-0600-6
Brown, R. T., Perwien, A., Faries, D. E., Kratochvil, C. J., & Vaughan, B. S. (2006). Atomoxetine in the management of children with ADHD: Effects on quality of life and school functioning. Clinical Pediatrics (Phila), 45(9), 819-827. https://doi.org/10.1177/000992280604500902
Cheng, J. Y., Chen, R. Y., Ko, J. S., & Ng, E. M. (2007). Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents-meta-analysis and meta-regression analysis. Psychopharmacology (Berl), 194(2), 197-209. https://doi.org/10.1007/s00213-007-0782-9
Flapper, B. C., Schoemaker, M. M., Flapper Boudien, C. T., & Schoemaker Marina, M. (2008). Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD. Developmental Medicine & Child Neurology, 50(4), 294-299. https://doi.org/10.1111/j.1469-8749.2008.03080.x
Flapper, B. C., Schoemaker, M. M., Flapper, Boudien C. T., & Schoemaker, Marina M. (2008). Effects of methylphenidate on quality of life in children with both developmental coordination disorder and ADHD. Developmental Medicine & Child Neurology, 50(4), 294–299. https://doi.org/10.1111/j.1469-8749.2008.03087.x
Kandemir, H., Kılıç, B. G., Ekinci, S., & Yüce, M. (2014). An evaluation of the quality of life of children with ADHD and their families. Anadolu Psikiyatri Dergisi, 15(3), 265–271. https://doi.org/10.5455/apd.35727
Klassen, A. F., Miller, A., & Fine, S. (2004). Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder. Pediatrics, 114(5), e541-e547. https://doi.org/10.1542/peds.2004-0613
Matza, L. S., Rentz, A. M., Secnik, K., Swensen, A. R., Revicki, D. A., Michelson, D., et al. (2004). The link between health-related quality of life and clinical symptoms among children with attention-deficit hyperactivity disorder. Journal of Developmental & Behavioral Pediatrics, 25(3), 166–174. https://doi.org/10.1097/00004703-200406000-00002
Newcorn, J. H., Spencer, T. J., Biederman, J., Milton, D. R., & Michelson, D. (2005). Atomoxetine treatment in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 44(3), 240-248. https://doi.org/10.1097/01.chi.0000155412.69909.32
Özkan, S. (1999). Yaşam Kalitesinin Ölçülmesi, WHOQOL-100 ve WHOQOL-BREF. Psikiyatri, Psikoloji, Psikofarmakoloji Dergisi, 7(2), 5-13.
Perwien, A. R., Faries, D. E., Kratochvil, C. J., Sumner, C. R., Kelsey, D. K., & Allen, A. J. (2004). Improvement in health-related quality of life in children with ADHD: An analysis of placebo controlled studies of atomoxetine. Journal of Developmental and Behavioral Pediatrics, 25(4), 264-271. https://doi.org/10.1097/00004703-200408000-00005
Perwien, A. R., Kratochvil, C. J., Faries, D. E., Vaughan, B. S., Spencer, T., & Brown, R. T. (2006). Atomoxetine treatment in children and adolescents with attention-deficit hyperactivity disorder: What are the long-term health-related quality-of-life outcomes? Journal of Child and Adolescent Psychopharmacology, 16(6), 713-724. https://doi.org/10.1089/cap.2006.16.713
Pongwilairat, K., Louthrenoo, O., Charnsil, C., & Witoonchart, C. (2005). Quality of life of children with attention-deficit/hyperactivity disorder. Journal of the Medical Association of Thailand, 88(8), 1062-1066.
Prasad, S., Harpin, V., Poole, L., Zeitlin, H., Jamdar, S., & Puvanendran, K. (2007). A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit/hyperactivity disorder (ADHD). Current Medical Research and Opinion, 23(2), 379-394. https://doi.org/10.1185/030573107X179380
Rebok, G., Riley, A., Forrest, C., Starfield, B., Green, B., Robertson, J., & et al. (2001). Elementary school-aged children's reports of their health: A cognitive interviewing study. Quality of Life Research, 10(1), 59-70. https://doi.org/10.1023/A:1016784312151
Riley, A. W., Coghill, D., Forrest, C. B., Lorenzo, M. J., Ralston, S. J., & Spiel, G. (2006). Validity of the health-related quality of life assessment in the ADORE study: Parent Report Form of the CHIP-Child Edition. European Child & Adolescent Psychiatry, 15(Suppl 1), i63–i71. https://doi.org/10.1007/s00787-006-0511-2
Riley, A. W., Spiel, G., Coghill, D., Dopfner, M., Falissard, B., Lorenzo, M. J., Preuss, U., & Ralston, S. J. (2006). Factors related to health-related quality of life (HRQoL) among children with ADHD in Europe at entry into treatment. European Child & Adolescent Psychiatry, 15(Suppl 1), i38-i45. https://doi.org/10.1007/s00787-006-0529-4
Üneri, Ö., & NÇ, M. (2007). Çocuklarda yaşam kalitesi kavramı ve yaşam kalitesi ölçeklerinin gözden geçirilmesi. Çocuk ve Gençlik Ruh Sağlığı Dergisi, 14(1), 48–56. https://doi.org/10.5455/cjpsy.10816
Üneri, Ö., Turgut, S., Öner, P., Bodur, Ş., & Rezaki, B. (2010). Quality of life in 8–12 years old children with attention deficit hyperactivity disorder. Çocuk ve Gençlik Ruh Sağlığı Dergisi/Turkish Journal of Child and Adolescent Mental Health, 17(1), 27–32. https://doi.org/10.1002/psp.781
Varni, J. W., Seid, M., & Kurtin, P. S. (2001). PedsQL™ 4.0: Reliability and validity of the Pediatric Quality of Life Inventory™ Version 4.0 Generic Core Scales in healthy and patient populations. Medical Care, 39(8), 800-812. https://doi.org/10.1097/01.MLR.0000017652.00300.55
Wallander, J. L., Schmitt, M., & Koot, H. M. (2001). Quality of life measurement in children and adolescents: Issues, instruments, and applications. Journal of Clinical Psychology, 57(4), 571-585. https://doi.org/10.1002/jclp.1041
Wehmeier, P. M., Schacht, A., & Barkley, R. A. (2010). Social and emotional impairment in children and adolescents with ADHD and the impact on quality of life. Journal of Adolescent Health, 46(3), 209–217. https://doi.org/10.1016/j.jadohealth.2009.07.015
Wehmeier, P. M., Schacht, A., Escobar, R., Hervas, A., & Dickson, R. (2012). Health-related quality of life in ADHD: A pooled analysis of gender differences in five atomoxetine trials. ADHD Attention Deficit and Hyperactivity Disorders, 4(1), 25–35. https://doi.org/10.1007/s12402-012-0083-7
Weiss, M. D., Gibbins, C., Goodman, D. W., Hodgkins, P. S., Landgraf, J. M., & Faraone, S. V. (2010). Moderators and mediators of symptoms and quality of life outcomes in an open-label study of adults treated for attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 71(4), 381–388. https://doi.org/10.4088/JCP.08m04510
Yang, P., Hsu, H. Y., Chiou, S. S., & Chao, M. C. (2007). Health-related quality of life in methylphenidate-treated children with attention-deficit-hyperactivity disorder: Results from a Taiwanese sample. Australian & New Zealand Journal of Psychiatry, 41(12), 998-1004. https://doi.org/10.1080/00048670701670183
